Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17652518

Proc. Natl. Acad. Sci. U.S.A. 2007 Jul 31 104 31 12837-42

Download in:

View as

Triples

General Info

PMID
17652518